Heron Therapeutics
HRTX
HRTX
160 hedge funds and large institutions have $330M invested in Heron Therapeutics in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 46 increasing their positions, 46 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
160
Holders Change
+9
Holders Change %
+5.96%
% of All Funds
2.32%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
27
Increased
46
Reduced
46
Closed
18
Calls
$4.7M
Puts
$391K
Net Calls
+$4.3M
Net Calls Change
+$2.27M
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$28M |
| 2 |
2
Millennium Management
New York
|
$8.77M |
| 3 |
3
D.E. Shaw & Co
New York
|
$7.47M |
| 4 |
4
Nuveen Asset Management
Chicago,
Illinois
|
$3.03M |
| 5 |
5
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$1.56M |
Top Sellers
| 1 |
CC
1
Clearline Capital
New York
|
$7.69M |
| 2 |
TC
2
Tejara Capital
London,
United Kingdom
|
$12.2M |
| 3 |
3
Morgan Stanley
New York
|
$551K |
| 4 |
MAM
4
Monaco Asset Management
Monaco
|
$5.02M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$22.5M |
